SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.
Bidard FC, Barrios C, Bianchini G, Brufsky AM, Chia S, Cortes J, Cristofanilli M, Curigliano G, Dawood S, Fasching PA, Gerratana L, Giordano A, Ignatiadis M, Iwata H, Janni W, Lim E, Kalinsky K, Ma CX, Mayer EL, Medford AJ, Mouabbi JA, O'Shaughnessy J, Park YH, Pascual J, Razavi P, Sammons S, Sandoval JL, Sisca L, Tarantino P, Wander SA, Werutsky G, Turner NA.
Bidard FC, et al. Among authors: dawood s.
NPJ Breast Cancer. 2026 Jun 8;12(1):80. doi: 10.1038/s41523-026-00967-4.
NPJ Breast Cancer. 2026.
PMID: 42259831
Free PMC article.
No abstract available.